RxDoctor Payments Data

Ryan Agostinelli, PA

Physician Assistant · Spokane, WANPI 1043763253

Payments from drug & device makers

$2,927in general payments, 2019–2025

Across 136 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$651
  • AbbVie$614
  • Corcept Therapeutics$297
  • Exact Sciences$283
  • Pfizer$248
  • Johnson & Johnson$149
  • plus $685 from 15 others

What the payments were for

  • Food & beverage$2,927100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,927 in reported general payments places this provider in the 90th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$73,348
Medicare patients
241
Services billed
808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban90$82,645
JardianceEmpagliflozin46$49,570
OzempicSemaglutide17$33,432
TrulicityDulaglutide19$31,265
XareltoRivaroxaban25$22,151
MounjaroTirzepatide16$16,881
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$7,180
Breo ElliptaFluticasone/Vilanterol11$6,482
Arnuity ElliptaFluticasone Furoate15$3,625
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen153$2,916
Tamsulosin Hcl140$2,418
Levothyroxine Sodium248$2,406
Omeprazole140$2,239
Lisinopril227$2,124
Atorvastatin Calcium179$2,038

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$248$82,64590 claims
Boehringer IngelheimJardiance$146$49,57046 claims
Lilly USA, LLCTrulicity, Mounjaro$57$48,14635 claims
Novo NordiskOzempic$651$33,43217 claims
Johnson & JohnsonXarelto$149$22,15125 claims
AbbVieSynthroid$614$53113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →